BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 02/10/2012

Draft Guidance for Industry on Initial Completeness Assessments for Type II Active Pharmaceutical Ingredient Drug Master Files Under the Generic Drug User Fee Amendments of 2012

The Food and Drug Administration (FDA or the Agency) is announcing the availability of a draft guidance for industry entitled "Initial Completeness Assessments for Type II API DMFs Under GDUFA." Under the Generic Drug User Fee Amendments of 2012 (GDUFA), holders of certain drug master files, namely, Type II active pharmaceutical ingredient (API) drug master files (DMFs) that are referenced in generic drug applications, or in amendments or prior approval supplements to these applications, will be required to undergo an initial completeness assessment in accordance with FDA criteria. This guidance is intended to clarify the criteria FDA will use in the initial completeness assessment.

Source: Federal Register — Food and Drug AdministrationOpen original release →